A transcriptional attenuation mechanism for the regulation of pyr operon expression in Bacillus subtilis in which the PyrR regulatory protein binds pyr mRNA at three sites with similar sequences to cause transcription termination in response to elevated pyrimidine nucleotide pools has been proposed (R. J. Turner, Y. Lu, and R. L. Switzer, J. Bacteriol. 176:3708-3722, 1994). Twenty-seven mutants with cis-acting defects in the repression by pyrimidines of ␤-galactosidase expression of a pyr-lacZ fusion-integrant were isolated as blue colonies on X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside) agar plates containing uracil and uridine after UV irradiation or treatment with mutagens or following mutD mutagenesis. These mutants showed normal repression of the chromosomal pyr operon by exogenous pyrimidines. Sequence analysis revealed 12 unique sites of mutation, which occurred in the conserved putative PyrR binding sequence (10 of the 12) or in the stem of the transcriptional terminator structure. These mutants strongly support the proposed model for regulation of the pyr operon.
Expression of the pyrimidine nucleotide biosynthetic (pyr) operon of Bacillus subtilis is regulated by a transcriptional attenuation mechanism (15, 21) . Largely on the basis of molecular genetic evidence, Turner et al. (21) and Lu et al. (15) concluded that exogenous pyrimidines act to promote termination at three attenuation sites located in the promoter-proximal end of the operon. These sites are located in the 5Ј leader, between the first (pyrR) and second (pyrP) genes of the operon, and between the second and third (pyrB) genes of the operon. For each attenuator the mRNA is predicted to fold into one of two mutually exclusive secondary structures, one of which can function as a factor-independent transcription terminator and the other of which is an antiterminator structure whose formation prevents formation of the terminator. The ratio between terminator and antiterminator structures is proposed to be regulated by the protein product encoded by the first gene of the operon, pyrR. The PyrR protein is believed to act by binding in a pyrimidine nucleotide-dependent manner to the 5Ј stem of the antiterminator, thereby interfering with formation of the antiterminator stem-loop and promoting formation of the alternative terminator structure, which leads to transcriptional termination. A clue to the identity of the putative PyrR binding site was obtained from identification of a highly conserved nucleotide sequence located in the 5Ј stem of each of the three proposed antiterminators of the pyr operon (21) .
Many aspects of the mechanism of regulation of the pyr operon can be studied by analysis of mutants that have lost normal regulation. We describe in this work the isolation and characterization of a collection of mutants which were defective in pyrimidine repression of expression of pyr-lacZ fusions. These mutants were obtained by screening for defects in repression of the expression of ␤-galactosidase by a pyr-lacZ fusion in which the promoter and 5Ј leader attenuator sequences from the pyr operon were transcriptionally fused to the lacZ gene and integrated into the B. subtilis chromosome. The mutants resulted from single base replacements that were heavily concentrated in the sequences previously identified as a putative PyrR binding site or in the stem of the postulated terminator structure. The results provide strong experimental support for the transcriptional attenuation model for regulation of the pyr operon proposed by Turner et al. (21) .
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. The bacterial strains and plasmids used in this study are described in Table 1 .
Luria-Bertani (LB) medium (3) was used as a rich medium for growth of both Escherichia coli and B. subtilis. For synthetic minimal media, CH medium (7) and Spizizen medium (20) were used for B. subtilis. Solid medium contained 1.5% agar. When necessary, the following nutrients were added: uracil (50 g/ml), uridine (50 g/ml), starch (1%), and individual amino acids (50 g/ml). Liquid media and agar plates were supplemented with antibiotics for selection as follows: ampicillin (100 g/ml) and chloramphenicol (10 g/ml). The ␤-galactosidase chromogenic substrate 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal) was used at 80 g/ml.
Construction of pyr-lacZ fusion-integrant strains. The vector used to construct a transcriptional fusion of the B. subtilis pyr promoter and 5Ј leader region to the E. coli lacZ gene was the E. coli vector pDH32 (10) . The pDH32 vector cannot replicate in B. subtilis, but it has flanking amyE front and back gene segments, which allow integrative recombination of the linearized plasmid at the amyE locus of the B. subtilis chromosome. We constructed two pyr-lacZ transcriptional fusion integrants, BGH39 and BGH64. BGH39 was constructed from pTS790 (22) and carries the B. subtilis pyr promoter, 5Ј leader, and pyrR gene fused to lacZ (Fig. 1) . BGH64 was constructed from pTS290 (21) and carries only the pyr promoter and 5Ј leader fused to lacZ. In both cases the plasmids were linearized by digestion with PstI and ScaI and used to transform strain DB104 to chloramphenicol resistance as described below.
Mutagenesis. For mutagenesis of strain BGH39, treatment with N-methyl-NЈ-nitro-N-nitrosoguanidine (MNNG) or 2-aminopurine and irradiation with UV were performed according to the procedures described by Miller (17) .
For mutD mutagenesis, the pTS290 plasmid was transformed in the E. coli mutD strain KD1067. The transformants were grown in multiple, separate tubes containing 5 ml of LB medium at 37ЊC overnight. The mutagenized plasmids were extracted, linearized, and transformed into B. subtilis DB104.
Selection and characterization of mutants. For chemical mutagenesis, mutagenized cells were plated on CH agar plates containing X-Gal and chloramphenicol and supplemented with uracil and uridine. Blue colonies that also lacked amylase activity, as determined by iodine staining of colonies restreaked on LB agar plates containing 1% starch, were isolated as candidates for mutants with defects in regulation of pyr expression. To ensure that only mutations in the pyr-lacZ fusion region were being studied, chromosomal DNA from the candi-date strains was prepared and used to transform to chloramphenicol resistance another culture of B. subtilis DB104, which had not been exposed to mutagens. The transformants were rescreened for blue color on X-Gal plates containing excess pyrimidines as before.
For mutD mutagenesis, B. subtilis DB104 transformants obtained from mutagenized and linearized plasmids were plated on LB agar plates containing chloramphenicol to select for integration of the plasmid into the chromosome at the amyE locus and then replica plated onto CH agar plates containing X-Gal with or without uracil and uridine and LB agar plates containing 1% starch and chloramphenicol. Blue colonies growing on plates supplemented with repressive levels of pyrimidines and showing no amylase activity on starchcontaining plates were isolated as the attenuator mutant candidates. All purified mutants were further characterized by ␤-galactosidase and aspartate transcarbamylase (ATCase) assays.
PCR amplification and sequencing of pyr attenuator DNA. PCR amplification was performed by using AmpliTaq DNA polymerase (Perkin-Elmer) for DNA amplification. Each 100-l reaction mixture contained 50 mM KCl, 10 mM Tris-HCl (pH 8.4), 1.5 mM MgCl 2 , 50 M each deoxynucleoside triphosphate, 0.5 pmol of each primer, 1 g of template DNA per ml, and 2 U of polymerase. The reaction mixture was heated to 94ЊC for 3 min and passed through 30 reaction cycles as follows: denaturation at 94ЊC for 1 min, primer annealing at 55ЊC for 30 s, and extension at 72ЊC for 45 s. After the completion of the cycles, the reaction was extended at 72ЊC for 15 min. Sequencing-grade Taq DNA polymerase (Promega, Madison, Wis.) was used for direct sequencing of PCR products as described by the manufacturer. DNA sequencing was carried out with a [␥-
32 P]ATP-labeled primer, purified DNA template from PCR amplification, and Taq DNA polymerase in a DNA Thermal Cycler (Perkin-Elmer Cetus) (13) . The Cycler conditions used for DNA sequencing were 95ЊC for 2 min followed by 30 reaction cycles of 95ЊC for 30 s, 65ЊC for 30 s, and 72ЊC for 1 min. DNA fragments were separated on 6% polyacrylamide-35% formamide slab gels.
Two synthetic primers, 5Ј-GGAGGCTTACTTGTCTGCTTTCTTC-3Ј (primer A-8) and 5Ј-CCCGGTCGACCCGTAATCTTACG-3Ј (primer A-7), were used for amplification of the target DNA region, and two [␥-32 P]ATP 5Ј-endlabeled oligonucleotides, 5Ј-GCCGATGATAAGCTGTC-3Ј (primer S-7) and 5Ј-GTTCGTCGAGAATGACAG-3Ј (primer S-2), were used for the sequencing of both DNA strands. The locations of these primers on the DNA integrated into the amyE locus are shown in Fig. 1 .
Recombinant DNA techniques. For B. subtilis preparation of competent cells and transformation were performed as described by Boylan et al. (5) , and for E. coli these procedures were performed as described by Cohen et al. (6) . For purification of amplified DNA fragments, PCR products were electrophoresed on 0.8% agarose gels and gel pieces of the proper band were cut out with a scalpel. The gel pieces were extracted with the QIAquick gel extraction kit (Qiagen, Hilden, Germany). Plasmid preparations used Qiagen columns according to the manufacturer's instructions. B. subtilis chromosomal DNA was isolated as described by Wilson (23) . Other DNA techniques were performed as described previously (19) .
Enzyme assays. For ATCase assays, 55-ml portions of cell cultures grown in Spizizen minimal medium with and without pyrimidines were harvested by centrifugation at a cell density corresponding to a turbidity of about 100 Klett units (no. 66 filter; late exponential growth phase) and the precipitated cells were washed with 0.9% NaCl and resuspended in 5.5 ml of 10 mM Tris-HCl-1 mM EDTA buffer (pH 8.0). The cells were disrupted by sonication and centrifuged at 16,000 ϫ g for 10 min, and the supernatant liquid was collected. ATCase activity was determined by the procedure of Bond et al. (4) and the colorimetric method of Prescott and Jones (18) .
␤-Galactosidase activity was determined as described previously (15, 16) . Cultures were grown in Spizizen minimal medium to a culture turbidity of approximately 100 Klett units, the cell density was measured (A 600 ), and 1 ml of cell culture was mixed with 10 l of toluene with vigorous vortexing. A 0.1-ml sample of the toluenized cells was used for assay. Specific activities were determined in Miller units (16) .
Protein content was determined by using the Coomassie protein assay reagent (Pierce, Rockford, Ill.) with bovine serum albumin as the standard.
RESULTS AND DISCUSSION
The first group of mutants with mutations in the pyr 5Ј leader attenuator region was isolated after chemical mutagenesis of strain BGH39, which contained a transcriptional fusion of the B. subtilis pyr promoter, 5Ј leader, and pyrR gene to the E. coli lacZ gene integrated into the chromosome at the amyE locus (Fig. 1) . A fusion that contained the pyrR gene was used so that the presence of two copies of the gene (one is also present in the normal chromosomal pyr operon) would reduce the chance of isolating mutations in the pyrR gene. Colonies of strain BGH39 were blue when they were grown on minimal medium plus X-Gal and white when the plates also contained uracil and uridine, demonstrating normal regulation of the pyr-lacZ fusion by exogenous pyrimidines. Mutant colonies were selected as those which remained blue even when grown on the indicator plates containing pyrimidines. The colonies were purified by restreaking, and DNA from the mutants was extracted and used to transform a culture of strain DB104 to chloramphenicol resistance, which is tightly linked to the pyr-lacZ fusion (Fig. 1) , so as to reduce the likelihood of isolating strains bearing multiple mutations. Nearly all of the transformants also carried resistance to repression of the pyr-lacZ fusion, as indicated by their blue color on X-Gal plates containing pyrimidines. Eighteen such mutant strains were purified and characterized ( Table 2 ). All of the mutant strains displayed normal regulation of the chromosomal pyr operon, as evidenced by ATCase assays of the cells grown on minimal medium with and without uracil plus uridine, but all were defective in the normal repression of ␤-galactosidase expression from the pyr-lacZ fusion. This demonstrated that the mutations were cis acting and were not located in the pyrR gene. DNA specifying the pyr promoter and 5Ј leader from the pyr-lacZ fusions of the mutant strains was amplified by PCR using primers that were complementary to fusion vector sequences that flank this region, so that the corresponding region from the normal pyr operon was not amplified. The amplified DNA from all 18 mutant strains was sequenced. In each case the sequence corresponding to nucleotides Ϫ35 through 150 of the pyr operon, numbering from the start of transcription as ϩ1, was determined. Mutations in seven loci were identified (Table 2) . That is, most of the mutations that we identified were isolated independently several times; only two of the seven mutations were isolated only once. All of the mutations were G-to-A transitions, as might be expected from the nature of the mutagens used.
In an attempt to isolate other types of cis-acting pyr regulatory mutants, we devised a protocol for mutD mutagenesis. Plasmid pTS290, which carries a transcriptional fusion of the B. subtilis pyr promoter and 5Ј leader to lacZ, was grown in the E. coli mutD strain KD1067, and the mutagenized plasmids were then linearized and transformed into B. subtilis DB104, with selection for chloramphenicol-resistant integrants at the amyE locus. Colonies displaying defects in the repression of pyr-lacZ expression by pyrimidines were selected on X-Gal plates. Nine mutants were isolated and shown to contain cisacting mutations affecting repression of the pyr-lacZ fusion ( Table 3 ). The DNA specifying the pyr promoter and attenuator from these mutants was amplified by PCR and sequenced as described above; eight different mutational sites were identified (Table 3) . Three of these mutations were identical to mutations which had been generated by the chemical mutagenesis procedure. Thus, 12 unique mutations in the pyr 5Ј leader region that lead to cis-acting defects in repression by pyrimidines were characterized.
Determination of the sites of mutations leading to regulatory defects within the pyr 5Ј leader-attenuator region gives valuable clues to the location of functionally important regions within this RNA. The mutations were not randomly distributed throughout the 5Ј leader region but were clustered within two relatively short segments (Fig. 2) . Most of the mutants were isolated multiple times from independent mutagenesis experiments. The properties of the mutants are quite readily interpreted in terms of the transcriptional attenuation model previously proposed for the B. subtilis pyr operon (21) .
Two of the 12 mutations (seven isolates) were located within the stem of the predicted stem-loop structure of a transcription terminator near the 3Ј side of the attenuator. Previous deletion mutagenesis had demonstrated that this region behaves as a transcription terminator in vivo and that it plays an important role in the repression by uracil of a pyr-lacZ fusion (21) . Both mutations in the terminator would disrupt G ⅐ C base pairs (24) to reduce the stability of the stem-loop structure by about 40%. The expected consequence of disrupting the terminator stem would be decreased transcriptional termination, leading to increased expression, whether or not PyrR is bound to the antiterminator stem. This prediction is consistent with the properties of the mutants in the present study. The fact that the terminator mutants could still be repressed about 1.8-fold by exogenous uracil indicates that some residual termination of transcription can take place with these mutants and that it can still be regulated by PyrR and the antiterminator. Ten of the 12 mutations (20 isolates) were located within or immediately adjacent to a sequence that is highly conserved in all three pyr attenuators (21) . The central portion of this conserved region forms part of the 5Ј half of the putative antiterminator stem-loop structure in each of the three regulatory regions, which is located so that base pairing of that segment with the 3Ј segment of the antiterminator hairpin prevents formation of the terminator stem-loop (21) (Fig. 2) . Turner et al. (21) have proposed that this conserved region forms the recognition site for the binding of the PyrR protein and that binding of PyrR prevents base pairing of this RNA segment with the 3Ј stem, thus permitting the terminator to form. The identification of so many mutations in this limited sequence that have defects in repression by pyrimidines confirms the region's importance in attenuation. The properties of these mutants can be easily explained by proposing that the mutated RNA strand has greatly reduced affinity for the PyrR protein. An important part of the PyrR binding sequence, as defined by these mutants, lies between G-23 and A-39. The mutations lying 5Ј to this region (A-5 to G) and 3Ј to it (A-43 to G and G-61 to A) were less derepressed than the others and generally showed somewhat greater residual repressibility (1.9-to 3.7-fold) than the others (1.0-to 1.6-fold, except for C-25 to U). This central region is precisely the region in which the regulatory sequences are most strongly conserved (Fig. 3) . The fact that mutations causing derepression ranging all of the way from A-5 to G-61 were isolated, however, indicates that the PyrR binding site or the attenuation mechanism may involve elements of sequence recognition or RNA secondary structure throughout this region. It should also be noted that 4 of the 10 mutations in this region are not in nucleotides whose sequence is conserved in all three of the pyr attenuators (Fig. 3) . All of these mutations lie outside of the 10-nucleotide core conserved sequence. If these mutations exert their effects on pyr expression by reducing PyrR binding, we suggest that they might do so by adversely affecting the folding of the RNA into a structure that is optimal for PyrR recognition. Further definition of the sequence and secondary structure elements required for PyrR binding will require in vitro mutagenesis and direct studies of RNA binding by the purified protein.
If the attenuator mutations in the antiterminator do indeed define the PyrR binding site, the nature of that site is quite different from that of the RNA sequence elements recognized by the B. subtilis trp RNA-binding attenuation protein, TRAP, which regulates transcriptional attenuation of the trpEDCFBA operon by a mechanism that is formally very similar to that proposed for the pyr operon (1, 2, 9) . TRAP has been shown to bind in a highly cooperative manner to a region of singlestranded RNA that contains tandem repeats of up to 11 GAG or UAG segments, optimally separated by 2-nucleotide spacer segments (1, 2) . No such pattern of repeated sequences is evident in the corresponding sequences of the three pyr attenuators (Fig. 3) . If several repeated sequences were critical for PyrR binding, mutations leading to loss of regulation would not be expected to be so highly concentrated in a short segment of the RNA. If cooperative binding of PyrR to several repeated sequences were a feature of pyr attenuation, as has been shown for TRAP binding to trp RNA, it is unlikely that single-basesubstitution mutations would lead to major defects in PyrR binding and regulation of expression in vivo. It has been shown that 3 of the 11 G/UAG repeats in trp RNA can be deleted with (21) . Outlined letters indicate nucleotides that are identical in all three attenuators. Underlining indicates the sequence that matches the AG box described by Henkin (11, 12 ; also see the text).
only a minor reduction in TRAP binding and that RNA segments containing only 6 or 7 repeats still bind reasonably well (1). Our results suggest that the PyrR binding site is confined to a shorter sequence and that PyrR binding is highly sensitive to single base changes in the RNA to which it binds.
We considered the possibility that the mutations in the antiterminator region might exert their effects through alterations in the secondary structure of the RNA in this region. Several of the mutations in the antiterminator would be predicted to disrupt base pairs in the antiterminator stem (Fig. 2) , but we believe that it is unlikely that the effect of these mutations on pyr expression is solely a consequence of the breaking of these base pairs. Such effects would be predicted to weaken the antiterminator structure and favor terminator formation, which would have led to reduced expression, especially when the cells were grown without pyrimidines, but all of the mutants showed increased expression. Furthermore, the effects of those mutations predicted to disrupt base pairing (C-25 to U, C-26 to U, G-28 to A, A-39 to G, and G-61 to A) were no greater than those of most of the mutations that were not predicted to disrupt base pairing. Finally, the calculated free energies of formation (24) of the antiterminator stem-loop structures in the mutants differ from that of the wild-type structure by 10% or less in all but three cases. The G-61-to-A mutation was predicted to destabilize the antiterminator structure somewhat more than the others, but it caused the smallest defects in regulation of any of the mutants. Two mutations, A-39 to G and A-43 to G, were predicted to form antiterminator structures of roughly 20% greater stability than the wild type, but the effects of these mutations were not obviously different from those of others for which the stability of the antiterminator was predicted to be decreased. The failure of the regulatory defects in these mutants to correlate with the calculated free energies of formation of their antiterminator structures suggests that the mutations do not exert their effects simply as a result of alterations in the secondary structure of this segment of the pyr mRNA.
We have noticed that the conserved CAGAGA sequence (underlined in Fig. 3 .) in the pyr attenuator sequence is identical to a segment of the B. subtilis tyrS gene leader, known as the AG box, which has been identified as a conserved element in the 5Ј leaders of several B. subtilis aminoacyl-tRNA synthetase genes that are controlled by transcriptional attenuation (11) . Henkin (12) has suggested that the AG box might be important in the control of expression of these genes, because mutations of two or three positions of that sequence in tyrS resulted in a significant drop in the level of expression, but a specific biochemical role for this sequence in regulation of tyrS expression has not been identified. The presence of the AG box in the pyr attenuators might suggest a more general role for this sequence element in attenuation in B. subtilis. If the AG box serves as a binding site for a regulatory protein in both cases, the consequences of binding must be different in the two systems, because mutations in the AG box caused elevated expression in pyr-lacZ fusions but led to reduced expression of tyrS.
